Frederik Nevens

5PUBLICATIONS
59CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersMolecular targetsCardiovascular medicine and haematology not elsewhere classifiedEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 30, 2023
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.

Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein

|Feb 23, 2023
Letter to the Editor: Survival in placebo-treated patients with severe alcohol-associated hepatitis.

Lukas Van Melkebeke, Lore Pollentier, Schalk Van der Merwe

|Feb 22, 2023
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial.

David Jones, Marco Carbone, Pietro Invernizzi

|Jul 21, 2021
Recanalization of portal axis after cavoportal hemitransposition in a liver transplant recipient with complete splanchnic thrombosis.

Mathias Clarysse, Alexander Wilmer, Yves Debaveye

|Aug 24, 2018
Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study.

Rosalie C Oey, Koos de Wit, Adriaan Moelker

Pageof 1